St Olavs Hospital, Department of Urology
Trondheim, Norway
NCT Number: NCT02347436
The known correlation between benign prostatic hypertrophy (BPH) and hypertension could be explained by 3 theoretical pathway models. Whether hypertension causes BPH, BPH causes hypertension or the two are caused by a common factor is currently unknown.
In this study it will be investigated whether hypertension is due to the direct effects of infravesical obstruction to urinary outflow in patients with benign prostatic hyperplasia. The approach will be blood pressure measurement in patients who will have a resection of the prostate.
Looking for future studies?
Notify MeUp to 65 year
Male
Observational
Trondheim, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7,5 months
one measurement 6 weeks pre-surgery, and ambulatory measurement during 6 months post-surgery
Time frame: 7,5 months
assessed by 'International prostate severity score' (questionnaire)
St. Olavs Hospital
Other
Effect of Transurethral Prostate Resection on 24 Hour Blood Pressure Measurement
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01050465
Acne Vulgaris, Acneiform Eruptions
View Trial DetailsNCT06568718
Genital Diseases, Genital Diseases, Male
Krasnodar, Russia
View Trial DetailsNCT06699563
Genital Diseases, Genital Diseases, Male
Tekirdağ, Turkey (Türkiye)
View Trial DetailsNCT06995963
Genital Diseases, Genital Diseases, Male
Gonesse, France
View Trial Details